LLY News and Press, Eli Lilly and Company From 05/28/24

2024-05-28 10:49:02 ET More on the markets BofA says a signal to sell global equities is closer to lighting up Nasdaq, S&P, Dow are mixed following long weekend News have trended negatively against the ACWI - BofA Ignore The Weather Vanes UBS Inve...

Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare Conference PR Newswire INDIANAPOLIS , May 28, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on ...

2024-05-28 08:30:00 ET Summary Novo Nordisk stock has easily outperformed the market over the past year. Novo Nordisk's growth potential through its weight loss drugs is expanding. Competition from rivals like Eli Lilly and Amgen could impact demand and pricing dynamics in the...

2024-05-28 04:39:00 ET Eli Lilly (NYSE: LLY) stock is already up by about 90% over the past year, and it could climb even higher. BMO Capital analyst Evan Seigerman recently raised his price target to $1,001 per share, which implies a gain of about 24% from recent prices. Seiger...

2024-05-27 07:02:07 ET Summary Altimmune is developing an anti-obesity drug, Pemvidutide, that shows promising results in targeting fat mass and promoting weight loss. The obesity treatment market is expected to grow exponentially, reaching $77 billion by 2030, creating a signific...

2024-05-27 01:45:30 ET Summary Gilead is sitting at one of the lowest valuations in the Big Pharma sector, with a high and sustainable 4.6% dividend yield available for new buyers. The stock has an enviable track record of rising strongly in price when turmoil hits Wall Street and...

2024-05-26 15:19:39 ET Summary Eli Lilly's shares reached new all-time highs after the company increased full-year revenue and EPS guidance. The company's growth is currently supply-constrained and the growth of tirzepatide in the near- and possibly medium-term should only be limi...

2024-05-26 13:36:00 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Great Time To Divest Before It Potentially Crashes Eli Lilly Remains Expensive Here - Minimal Margin Of Safety The FTC Cracks Down On Novo Nordisk's Ozempic SA Asks: Is Eli Lilly or Novo ...

2024-05-26 11:15:37 ET Summary T. Rowe Price Blue Chip Growth ETF is an actively managed ETF with a portfolio of 74 companies. TCHP focuses on companies with leading market positions, seasoned management teams, and strong financial health. TCHP shows strong quality metrics and...

2024-05-26 10:15:00 ET Summary Parnassus Investments is a fundamental, bottoms-up investment firm offering responsible investment funds to the public. Parnassus Investments integrates comprehensive ESG evaluations with fundamental financial analysis to select investments. The Fund...